Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $75.5M | $187M | $501M |
| Revenue growth | — | 147.9% | 167.7% |
| Operating income | -$157M | -$27.2M | $17.3M |
| Operating margin | -208.2% | -14.5% | 3.5% |
| Net income | -$172M | -$28.9M | $86.9M |
| Net margin | -227.6% | -15.4% | 17.4% |
| EPS (diluted) | -$3.14 | -$0.29 | $0.39 |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | $5.73M | $52.2M | $246M |
| Capital expenditures | $116M | $142M | $411M |
| Free cash flow | -$110M | -$89.6M | -$165M |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $68.9M | $405M | $565M |
| Total assets | — | $1.15B | $2.94B |
| Total liabilities | — | $55.3M | $1.12B |
| Shareholders' equity | $305M | $1.10B | $1.82B |
| Retained earnings | — | -$683M | -$596M |
| Shares (wtd avg diluted) | 54.8M | 99.6M | 223M |
Every figure is extracted from IREN Ltd’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.